Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018226

Chief Legal Officer and GC acquired 58,191 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harsch Mutya · Chief Legal Officer and GC

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-09 Grant or award : show line 1 in the form +7,548 7,548 D
2020-03-09 Grant or award : show line 2 in the form +50,643 58,191 D

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 3 in the form Stock Options +29,620 $10.73 2028-02-27 29,620 29,620 D
2020-03-09 Grant or award : show line 4 in the form Stock Options +41,643 $6.37 2029-01-01 41,643 41,643 D
2020-03-09 Grant or award : show line 5 in the form Stock Options +57,086 $6.81 2030-02-24 57,086 57,086 D
Loading xslF345X03/doc4.xml…